For full functionality of this site it is necessary to enable JavaScript. Here are the instructions how to enable JavaScript in your web browser.

Scientific Program

IC19 - Unmasking the Polyp: The Complete Guide to PCV

28/11/2026
Shalia
10:00
10:55

KSOSID1522

Dr.Divya Mohanchandran Nair
Unmasking the Polyp: The Complete Guide to PCV
Polypoidal Choroidal Vasculopathy (PCV) presents a unique diagnostic and therapeutic challenge, often masquerading as typical neovascular Age-Related Macular Degeneration (nAMD) but demanding entirely distinct management strategies. This Instruction Course offers a systematic, high-yield guide to navigating the PCV spectrum. The curriculum begins by establishing a clear clinical definition and outlining the phenotypic hallmarks that differentiate PCV from wet AMD. It then deeply explores multimodal imaging, training attendees to interpret both the Gold Standard Indocyanine Green Angiography (ICGA) and essential non-invasive modalities like SD-OCT and OCTA. The course concludes by outlining current medical treatment algorithms (Anti-VEGF and PDT) and the acute, surgical management of sight-threatening submacular hemorrhages.
The Chief Instructor is a practicing Vitreoretinal Retinal Surgeon for the past 8 years, after completing her medical retinal and Vitreo-retinal Surgery fellowship. She has a high volume practice managing complex macular pathologies like  PCV and AMD  with intravitreal injections and PPV. She has previously conducted Instruction courses in KSOS as chief instructor and has been the co-instructor in multiple ICs in KSOS and AIOS. She also has been a dedicated PG trainer and retina fellowship metor for 4 years.
Membership No Name Topic ORDER NO Duration
KSOSID1306 Dr.Vineetha Prakasam PCV: Clinical Presentation, Definition, and Differentiation from Wet AMD 1 8
KSOSID0757 Dr.Rajesh P Mapping the Network: Angiographic (FFA and ICG) Essentials in PCV 2 8
KSOSID1003 Dr.Prakash V S Beyond the Dye: Mastering SD-OCT and OCTA in PCV 3 8
KSOSID1621 Dr.Ganadin Ajoy Targeting the Network: The PCV Therapeutic Arsenal (Anti-VEGF & PDT) 4 8
KSOSID1522 Dr.Divya Mohanchandran Nair Code Red in PCV: Algorithms for Acute Subretinal Hemorrhage 5 8
Non Member Dr.Vasumathy Vedantham Clinical outcomes of switching to Brolucizumab in refractory PCV 6 8